Germany’s ThyssenKrupp to Sell Brazilian Steel Plant to Ternium

Germany’s ThyssenKrupp to Sell Brazilian Steel Plant to Ternium
Latest step in German company’s unsuccessful investment push into the Americas

FRANKFURT—German engineering giant Thyssenkrupp AG is in talks with Ternium SA to sell its large steel plant in Brazil, a step that would finish unwinding the German company’s unsuccessful investment push in the Americas, according to people familiar with the matter.
The discussions are at an advanced stage and could be concluded by year-end, those people said, adding there is no guarantee a deal will take place. One significant potential stumbling block is the fact that Ternium would likely want to pay less than the plant’s current book value of roughly €2 billion ($2.17 billion).
Any deal below that value would hit ThyssenKrupp’s equity cushion, which is already thin, according to analysts. It was unclear whether other bidders are also eyeing the steel-slab plant, which cost Thyssenkrupp roughly $6.8 billion to build when finished in 2010. In 2013, Thyssenkrupp sold its U.S. steel plant to ArcelorMittal and Nippon Steel & Sumitomo Metal Corp. for $1.55 billion.

Thyssenkrupp said in an emailed statement that the company is seeking to dispose of Companhia Siderúrgica do Atlântico, or CSA, adding it was a normal course of business to hold talks with potential buyers.
A Ternium investor-relations official declined to speak with The Wall Street Journal. The company’s press office didn’t immediately respond to an email.
Ternium is a Luxembourg-based producer of flat and long steel products with a strong presence in Latin America.
CSA has an annual production capacity of 5 million tons. The plant swing to a €39 million operating profit in the third quarter of the fiscal year ending Sept. 30, up from a €25 million loss in the same quarter last year.
Selling the Brazilian steel unit would help ThyssenKrupp Chief Executive Heinrich Hiesinger’s effort to shift the company away from steel operations.
Steel prices in Europe have come under pressure in recent years, due to anemic steel demand growth and ​a sudden flood of steel shipments from China, where shrinking demand led to a glut in steel production. Large steel producers in Europe such as ThyssenKrupp, ArcelorMittal and Tata Steel ​Ltd ​have responded to the supply glut over the years by ​shutting loss-making production capacity, laying off thousands of workers and/or disposing assets.
ThyssenKrupp, whose roots trace back more than 200 years and at some point gained notoriety for its weapons including the giant World War I-era howitzer known as Big Bertha, has also said it is in talks to transfer its European steel operations into a joint venture with Tata Steel Ltd.​
The talks with Tata appeared to have been cast into doubt on Monday, however, when India-based conglomerate Tata Group, the founder and owner of Tata Steel, ousted its group chairman Cyrus Mistry in a surprise move.

Mr. Mistry, also chairman of Tata Steel, was a key supporter of talks to combine Tata’s remaining European steel operations with those of ThyssenKrupp. Analysts at Kepler Chevreux said it was still too early to draw conclusions but “we think the risks for a JV between Tata Steel Europe and Thyssenkrupp Steel Europe have increased.”
They added the joint venture might be delayed by at least six months “at the very least” given growing risk of resistance to the deal from Thyssen’s union and works council.
Additionally, the shape such a joint venture would take is currently also unclear. While ThyssenKrupp’s management prefers to tie-up its German steel plants with Tata’s large mill in the Dutch city of Ijmuiden, Tata appears willing to include its U.K. plant called Port Talbot into the joint venture, people familiar with the matter said.
That could be an unattractive alternative for ThyssenKrupp because Port Talbot has suffered hefty losses over the years and has substantial pension liabilities.

DJ Germany's ThyssenKrupp to Sell Brazilian Steel Plant to Ternium

DJ Germany's ThyssenKrupp to Sell Brazilian Steel Plant to Ternium
By Eyk Henning
FRANKFURT--German engineering giant ThyssenKrupp AG is in talks with Ternium SA to sell its large steel plant in Brazil, a step that would finish unwinding the German company's unsuccessful investment push in the Americas, according to people familiar with the matter.
The discussions are at an advanced stage and could be concluded by year-end, those people said, adding there is no guarantee a deal will take place. One significant potential stumbling block is the fact that Ternium would likely want to pay less than the plant's current book value of roughly EUR2 billion ($2.17 billion).
Any deal below that value would hit ThyssenKrupp's equity cushion, which is already thin, according to analysts. It was unclear whether other bidders are also eyeing the steel-slab plant, which cost ThyssenKrupp roughly $6.8 billion to build when finished in 2010. In 2013, ThyssenKrupp sold its U.S. steel plant to ArcelorMittal and Nippon Steel & Sumitomo Metal Corp. for $1.55 billion.
ThyssenKrupp said in an emailed statement that the company is seeking to dispose of CSA, adding it was a normal course of business to hold talks with potential buyers.
A Ternium investor-relations official declined to speak with The Wall Street Journal. The company's press office didn't immediately respond to an email.
Ternium is a Luxembourg-based producer of flat and long steel products with a strong presence in Latin America.

>>> Zodiac Pool Solutions to be acquired by Rhone from Carlyle Group

Zodiac Pool Solutions to be acquired by Rhone from Carlyle Group
Not Zodiac but Carlyle

Rhône, a private equity firm, will acquire Zodiac Pool Solutions SAS, a French residential pool and spa business, fromtheCarlyle Group, a private equity firm. No financial terms were revealed.
The transaction is expected to close promptly. In March, the Carlyle Group hired Credit Suisse to shop the business and reportedly hoped to sell it for around USD 800m, according to a newswire report.
Zodiac, in business for more than 100 years, makes equipment and solutions for in-ground residential swimming pools and spas. The company, with 1,300 employees worldwide, has grown over the past three years by acquiring in-ground residential swimming pool companies.
Press release:
The Carlyle Group has accepted an offer from investment funds affiliated with Rhône to acquire Zodiac Pool Solutions SAS and its global residential pool and spa business, including its family of premium brands and all 1,300 employees worldwide, the companies announced today. Financial terms of the agreement were not disclosed. The transaction, subject to regulatory approvals, is expected to close promptly.
With its global headquarters in Paris, France and operational headquarters in Vista, Calif., Zodiac is a global manufacturer of premium residential pool equipment and automation solutions. The acquisition will include the Zodiac leadership team and its high-profile brand portfolio including Zodiac® Pool, Jandy® Pro Series, Polaris®, iAquaLink®, Cover-Pools®, MagnaPool, CaretakerTM, SAVI and Nature2®.
Rhône, established in 1996, is a global asset management firm with a focus on investments in market leading businesses with a pan-European or transatlantic presence and expansion prospects. Rhône has offices in London and New York and currently holds investments in a diversified portfolio of companies, including investments in the business services, chemicals, consumer products, industrial products, food, packaging, specialty materials and transportation sectors.
Zodiac has established itself as one of the global pool and spa industry's major players. Over the past three years, Zodiac has grown its premium brands through a strategic focus on its core global in-ground residential swimming pool business and an emphasis on customer-driven technological innovation across its product portfolio. This focus positioned Zodiac well during the pool construction market's recovery.
Recent strategic acquisitions by Zodiac include SAVI, a U.S. pool and spa lighting company, in 2014; Pool Resources, an Australian distributer of pool chemicals; Two10, a South African producer of pool chemicals; MagnaPool, an Australian company specializing in pool mineral water systems; and SET, a German company specializing in heating systems for swimming pools. Pool Resources, Two10, Magnapool and SET were acquired in 2013. Additionally, Cover-Pools, a U.S. manufacturer of automated pool covers, was acquired in 2008.
The Carlyle Group acquired Jandy in 2006 and Zodiac in 2007. The Zodiac brand was first registered in 1909.
"Based on our strong financial performance and growth over the past three years, culminating in a record year in 2016, the timing was right for new investment from a new partner," said Bruce Brooks, Zodiac's CEO since 2011. "We are proud of our company's achievements working with Carlyle, and we are excited about building on our accomplishments with Rhône. Rhône is great partner for Zodiac, and this is excellent news for our employees, customers, vendors and the pool and spa industry. We look forward to building on Zodiac's heritage of excellence to drive ever greater technological innovation and quality as we work to grow Zodiac's market share across all of its premium brands."

>>> US Gapping down:

Gapping down:

In reaction to disappointing earnings/guidance:
  • UA -15%, SONC -13.0%, NLSN -7.4%, EAT -6.3%, PII -6.3.%. WHR -6.1%, JBLU -3.7%, CAT -2.5%, NVS -2.3%, WAT-1.7%, LLY -1.5%, MMM -1.3%.
Other news:
  • DPRX -85.5% (announces that the OneStep-1 and OneStep-2 Phase 3 clinical trials of Locilex in patients with mild infections of diabetic foot ulcers did not meet the primary clinical endpoint standardized wound care),
  • FCEL -16.2% (discloses its Beacon Falls Energy Park project was not selected for contract negotiations under the The New England Clean Energy Request for Proposals),
  • PLG -10.5% (will raise $40 mln through bought deal financing of 22,230,000 common shares at $1.80/share),
  • MTL -10.4% (following Monday's 35% move higher),
  • BPL -5.2% (priced upsized offering of 7.75 mln limited partnership units (from 7.5 mln) at $66.05 per LP Unit),
  • LULU -3.2% (moving lower on UA comments),
  • CRZO -2.0% (prices upsized underwritten public offering of 6 mln shares (from 5 mln) of its common stock for total gross proceeds of approximately $225 mln),
  • NKE -1.7% (moving lower on UA comments),
  • SKX -1.3% (moving lower on UA comments).
Analyst comments:
  • CALA -20.3% (initiated with a Sell at Citigroup),
  • SPN -8.4% (downgraded to Neutral from Buy at Citigroup),
  • CLVS -7.7% (initiated with a Sell at Chardan Capital Markets; tgt $15),
  • VFC -1.5% (downgraded to Hold from Buy at Deutsche Bank, downgraded to Neutral from Buy at Citigroup, VFC target lowered to $68 at Telsey Advisory Group following yesterday morning's Q3 earnings).

SKY News : Women drink almost as much alcohol as men, global study finds

Women drink almost as much alcohol as men, global study finds
Research looking at the drinking habits of four million people finds the gap is closing, especially among young adults.

Women have caught up with men when it comes to drinking alcohol, new research has found.
The trend is most evident among young adults, according to the findings.
The researchers looked at the drinking habits of four million people born between 1891 and 2000 all over the world - by examining 68 studies on alcohol consumption.
They found that among those born in the early 1900s, men were:
:: 2.2 times more likely than women to consume alcohol;
:: Three times more likely to drink in ways "suggestive of problematic use"
:: 3.6 times more likely to experience alcohol-related harms

Image Caption:Doctors recommend that men and women do not drink more than 14 units per week
But that ratio changes dramatically when examining data relating to people born in the late 1900s. The study found that men were:
:: 1.1 times more likely than women to consume alcohol
:: 1.2 times more likely to drink problematically
:: 1.3 times more likely to experience alcohol-related harms.
The researchers concluded: "These results have implications for the framing and targeting of alcohol use prevention and intervention programmes.
"Alcohol use and alcohol use disorders have historically been viewed as a male phenomenon.
"The present study calls this assumption into question and suggests that young women in particular should be the target of concerted efforts to reduce the impact of substance use and related harms."
The study, by researchers from the National Drug and Alcohol Research Centre of the University of New South Wales, Australia, was published in the journal BMJ Open.

Emily Robinson, director of campaigns at Alcohol Concern, agreed with the findings, denouncing "a concerted effort from the alcohol industry to market products and brands specifically to women".
She said "alcohol is so cheap and easily available, it's become an everyday grocery item", and called for "mandatory health warnings on alcohol products" and a mass media campaign to raise awareness.
Portman Group, the trade group of alcohol producers, said the findings do not "reflect the real-life evidence of how women drink in the UK today".
A spokesman said: "Official data shows significant declines in women's alcohol consumption, frequency of drinking and binge-drinking rates over the last decade and today 84% of women do not exceed low-risk guidelines."
The Chief Medical Officers' guideline for both men and women is that it is "safest not to drink regularly more than 14 units per week, to keep health risks from drinking alcohol to a low level."
If drinking as much as 14 units per week, it is best to spread this evenly over 3 days or more, the guidelines recommend.

>>> US Gapping Up:

Gapping Up:
In reaction to earnings/guidance:
  • CR +8.2%, RMBS +6.8%, SWFT +5.8%, ORAN +5.1%, BHI +4.5%, CLGX+4.3%, RDY +3.7%, KKR +3.6%, BAX +3.2%, KEY +3.1%, VLO +2.9%, UTX+2.7%, ALSN +2.5%, PG +2.3%, UA +2.0%, MRK +1.6%, LMT +1.4%, GM+1.3%
Select metal/mining names seeing strength amid gains in underlying metals prices:
  • HMY +3.3%, CLF +3.2%, MUX +3.1%, GFI +2.7%, VALE +2.6%, RIO +2.4%,BHP +1.6%, GOLD +1.3%, ABX +1.3%, GDX +1.0%, AU +1.0%.
Other news:
  • SAEX +50.3% (received approx $24.4 mln of tax credit certificates from the state of Alaska's Department of Revenue; says received sooner than expected),
  • GBT +18.3% (agrees w/ the FDA on the design of its pivotal trial for GBT440 in adults and adolescents with sickle cell disease; expected to begin screening patients by December; decides to discontinue its research and development activities related to GBT18713; Chief Medical Officer Dr. Eleanor Ramos retires),
  • EYES +16.2% (announces the first successful implantation and activation of a wireless visual cortical stimulator in a human subject),
  • PSTI +11.2% (to sell approx. 16.89 mln shares of common stock at $1.77/share to China-based Innovative Medical Management),
  • CWEI +8.0% (Clayton Williams announces agreement to sell Giddings area assets for $400 million; names Patrick Cooke as COO),
  • CANF +7.4% (announces agreement with Chong Kun Dang Pharma for the exclusive right to distribute CF102 for the treatment of liver cancer in South Korea for up to $3 mln in upfront/milestone payments, plus a % of royalties on net sales in the low twenties),
  • WINT +7.4% (releases data from lung deposition study in non-human primates demonstrating uniform distribution of aerosolized KL4 surfactant in all regions of the lung),
  • SYT +1.4% (modest relief following yesterday's weakness)
  • BMY +1.3% (announces results from CheckMate-205; primary endpoint of objective response rate was 73% overall, which was consistent across patient subgroups)

>>> US Early pre-market gappers

Early pre-market gappers
Gapping up: SAEX +50.3%, PSTI +11.2%, CWEI +8.0%, CANF +7.4%, RMBS+6.8%, SWFT +5.8%, ORAN +5.1%, BHI +4.5%, CLGX +4.3%, RDY +3.7%, KKR+3.6%, HMY +3.3%, BAX +3.2%, BT +3.2%, MUX +3.1%, KEY +3.1%, VLO +2.9%,CLF +3.2%, YNDX +2.8%, QTM +2.7%, GFI +2.7%, UTX +2.7%, VALE +2.6%, RIO +2.4%, STX +2.3%, PG +2.3%, VOD +2.0%, UA +2.0%, MRK +1.6%, BBL+1.6%, BHP +1.6%, SYT +1.4%, NVO +1.4%, LMT +1.4%, X +1.4%, GOLD +1.3%,ABX +1.3%, GM +1.3%, BMY +1.3%, GDX +1.0%, AU +1.0%.
Gapping down: CALA -20.3%, SONC -13.0%, PLG -10.5%, MTL -10.4%, SPN-8.4%, NLSN -7.4%, EAT -6.2%, BPL -5.2%, WHR -4.2%, DB -2.8%, CAT -2.5%,NVS -2.3%, GWPH -2.2%, CRZO -2.0%, WAT -1.7%, STM -1.7%, LLY -1.5%, VFC-1.5%, MMM -1.3%, CS -1.1%.

(GS) Stock Picking in the ‘Reflation Rotation’

What just happened? Separating sectors from factors

Since 10-year Bund yields bottomed on July 8, there has been a clear sector rotation in Europe, with Banks up c.24%, Basic Resources up c.17% and Autos up c.16%. Meanwhile, Healthcare, Utilities and Food and Beverages

are down c.7%, 3% and 2% respectively. In this note, we employ GS sectorneutral IP factors to distinguish between the recent rotation in sectors and that seen in factors. Since July 8, we find that sector-neutral Value is up >5% and Growth is up c.4%. Meanwhile, the Volatility and Size factors have underperformed, in each case reversing the performance trend seen in 1H.

 

A case study in 10-year Bund yields

In a bid to help investors position from here, we study the historical relationship between European factor performance and 10-year Bund yields. We find that when 10-year Bund yields rise (which our economists

believe is likely from here), there is a significant positive impact on the performance of our IP Value and IP Growth factors and a significant negative impact on the IP Returns, IP Volatility and IP Size factors.

 

Factors to focus on now

Our economists forecast further upside to 10-year yields on US Treasuries and German Bunds from here. On that basis, our 10-year case study suggests that stocks with High Growth, High Volatility and Low Returns (relative to

sector peers) should outperform. Conversely, stocks with Low Growth, Low Volatility and High Returns look vulnerable. In this context we also note that Low Growth and Low Vol factor ‘tails’ currently trade at stretched valuations.

 

Identifying ‘Rotation Catch-Up Candidates’

We present a list of 23 ‘Rotation Catch-Up Candidates’, including Buy rated Accor, Colonial, Fresenius Medical Care, Ingenico, Mediaset and Shire. These stocks all screen as having higher growth, higher volatility and lower returns than sector peers. Yet, despite exposure to these recently strong ‘factor tails’, they have not outperformed since the start of the bond sell-off in early July. We also present a list of stocks that appear particularly vulnerable on a sector-relative basis given their low growth, low volatility and high returns, exposures which have historically been negatively correlated with 10yr Bund yields. These include Sell-rated Endesa, Austrian Post, Atlas Copco, bpost and Sandvik.